|
1
|
Huang J, Chan SC, Ko S, Lok V, Zhang L,
Lin X, Lucero-Prisno DE III, Xu W, Zheng ZJ, Elcarte E, et al:
Updated disease distributions, risk factors, and trends of
laryngeal cancer: A global analysis of cancer registries. Int J
Surg. 110:810–819. 2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Japan Society for Head and Neck Cancer
Registry Committee: Report of head and neck cancer registry of
Japan. http://wwwjshncuminnejp/pdf/HNCreport_2020pdf.
|
|
3
|
General information of cancer in Japan:
Laryngeal cancer. https://ganjoho.jp/reg_stat/statistics/stat/cancer/11_larynx.html
(In Japanese).
|
|
4
|
Koyanagi YN, Matsuo K, Ito H, Wakai K,
Nagata C, Nakayama T, Sadakane A, Tanaka K, Tamakoshi A, Sugawara
Y, et al: Cigarette smoking and the risk of head and neck cancer in
the Japanese population: A systematic review and meta-analysis. Jpn
J Clin Oncol. 46:580–595. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Đokanović D, Gajanin R, Gojković Z,
Marošević G, Sladojević I, Gajanin V, Jović-Đokanović O and Amidžić
L: Clinicopathological characteristics, treatment patterns, and
outcomes in patients with laryngeal cancer. Curr Oncol.
30:4289–4300. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mackie TR: From model-based dose
computation to tomotherapy. Med Phys. 50 (Suppl 1):S70–S73.
2023.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Takeda M, Takahama T, Sakai K, Shimizu S,
Watanabe S, Kawakami H, Tanaka K, Sato C, Hayashi H, Nonagase Y, et
al: Clinical application of the FoundationOne CDx assay to
therapeutic decision-making for patients with advanced solid
tumors. Oncologist. 26:e588–e596. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Poeta ML, Manola J, Goldwasser MA,
Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D,
Saunders J, et al: TP53 mutations and survival in squamous-cell
carcinoma of the head and neck. N Engl J Med. 357:2552–2561.
2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Agrawal N, Frederick MJ, Pickering CR,
Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et
al: Exome sequencing of head and neck squamous cell carcinoma
reveals inactivating mutations in NOTCH1. Science. 333:1154–1157.
2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cancer Genome Atlas Network. Comprehensive
genomic characterization of head and neck squamous cell carcinomas.
Nature. 517:576–582. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Forastiere AA, Goepfert H, Maor M, Pajak
TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et
al: Concurrent chemotherapy and radiotherapy for organ preservation
in advanced laryngeal cancer. N Engl J Med. 349:2091–2098.
2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fasaludeen A, Kumar RR, Rafi M, Nazeer F,
Prakasan AM, Kumar N, George P, Ramadas K and Thommachan KC:
Outcomes of organ preservation treatment in advanced laryngeal
carcinoma: A retrospective analysis from a single institution. Mol
Clin Oncol. 18(1)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
National Cancer Institute website:
Laryngeal cancer treatment–health professional version. https://www.cancer.gov/types/head-and-neck/hp/adult/laryngeal-treatment-pdq#_317_toc.
|
|
14
|
Zanoni DK, Patel SG and Shah JP: Changes
in the 8th Edition of the American Joint Committee on Cancer (AJCC)
staging of head and neck cancer: Rationale and implications. Curr
Oncol Rep. 21(52)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sano D, Tanabe T, Kubota A, Miyamoto S,
Tanigaki Y, Okami K, Komatsu M, Ikoma R, Suzuki K, Akazawa Y, et
al: Addition of S-1 to radiotherapy for treatment of T2N0 glottic
cancer: Results of the multiple-center retrospective cohort study
in Japan with a propensity score analysis. Oral Oncol.
99(104454)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bandoh N, Goto T, Kato Y, Kubota A, Sakaue
S, Takeda R, Hayashi S, Hayashi M, Baba S, Yamaguchi-Isochi T, et
al: BRAF V600E mutation co-existing with oncogenic mutations is
associated with aggressive clinicopathologic features and poor
prognosis in papillary thyroid carcinoma. Asian J Surg. 47:413–419.
2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yanagita E, Yamada H, Kobayashi T, Aimono
E, Nakamura K, Hirasawa A and Nishihara H: The DNA integrity number
and concentration are useful parameters for successful
comprehensive genomic profiling test for cancer using
formalin-fixed paraffin embedded tissue. Pathol Int. 73:198–206.
2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Malm IJ, Rooper LM, Bishop JA, Ozgursoy
SK, Hillel AT, Akst LM and Best SR: Molecular and immunologic
analysis of laryngeal squamous cell carcinoma in smokers and
non-smokers. Am J Otolaryngol. 40:213–217. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mayne ST, Cartmel B, Kirsh V and Goodwin
WJ Jr: Alcohol and tobacco use prediagnosis and postdiagnosis, and
survival in a cohort of patients with early stage cancers of the
oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev.
18:3368–3374. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kondo T, Nakano Y, Adachi S and Murohara
T: Effects of tobacco smoking on cardiovascular disease. Circ J.
83:1980–1985. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Parmar MP, Kaur M, Bhavanam S, Mulaka GSR,
Ishfaq L, Vempati R, C MF, Kandepi HV, Er R, Sahu S and Davalgi S:
A systematic review of the effects of smoking on the cardiovascular
system and general health. Cureus. 15(e38073)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Peters TT, van Dijk BA, Roodenburg JL, van
der Laan BF and Halmos GB: Relation between age, comorbidity, and
complications in patients undergoing major surgery for head and
neck cancer. Ann Surg Oncol. 21:963–970. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Browman GP, Wong G, Hodson I, Sathya J,
Russell R, McAlpine L, Skingley P and Levine MN: Influence of
cigarette smoking on the efficacy of radiation therapy in head and
neck cancer. N Engl J Med. 328:159–163. 1993.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fong PY, Tan SH, Lim DWT, Tan EH, Ng QS,
Sommat K, Tan DSW and Ang MK: Association of clinical factors with
survival outcomes in laryngeal squamous cell carcinoma (LSCC). PLoS
One. 14(e0224665)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sasco AJ, Secretan MB and Straif K:
Tobacco smoking and cancer: A brief review of recent
epidemiological evidence. Lung Cancer. 45 (Suppl 2):S3–S9.
2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sheng K, Molloy JA and Read PW:
Intensity-modulated radiation therapy (IMRT) dosimetry of the head
and neck: A comparison of treatment plans using linear
accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol
Biol Phys. 65:917–923. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chatterjee S, Mallick I, Chakraborty S,
Prasath S, Arunsingh M, Achari RB, Arun B, Nallathambi C,
Pattatheyil A and Sen S: Helical radiotherapy in early laryngeal
cancers could lead to excess local recurrence: Lessons from a phase
II prospective study. Clin Oncol (R Coll Radiol). 32:e67–e75.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bolukbas MK, Turna M, Karaca S and Basaran
H: Results of radiotherapy in squamous cell laryngeal cancer: A
tomotherapy center experience. Indian J Cancer. 59:330–336.
2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
|
|
30
|
Forastiere AA, Zhang Q, Weber RS, Maor MH,
Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, et
al: Long-term results of RTOG 91-11: A comparison of three
nonsurgical treatment strategies to preserve the larynx in patients
with locally advanced larynx cancer. J Clin Oncol. 31:845–852.
2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lefebvre JL, Rolland F, Tesselaar M,
Bardet E, Leemans CR, Geoffrois L, Hupperets P, Barzan L, de
Raucourt D, Chevalier D, et al: Phase 3 randomized trial on larynx
preservation comparing sequential vs alternating chemotherapy and
radiotherapy. J Natl Cancer Inst. 101:142–152. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Timmermans AJ, de Gooijer CJ,
Hamming-Vrieze O, Hilgers FJ and van den Brekel MW: T3-T4 laryngeal
cancer in The Netherlands cancer institute; 10-year results of the
consistent application of an organ-preserving/-sacrificing
protocol. Head Neck. 37:1495–1503. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shelan M, Anschuetz L, Schubert A,
Bojaxhiu B, Aebersold DM, Elicin O and Giger R: Superior
loco-regional control after primary surgery compared to
chemo-radiotherapy for advanced stage laryngeal cancer. Front
Oncol. 13(1132486)2023.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bhattacharyya T and Kainickal CT: Current
status of organ preservation in carcinoma larynx. World J Oncol.
9:39–45. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lechien JR, Chiesa-Estomba CM and Hans S:
Practical considerations for choosing transoral laser microsurgery
versus transoral robotic surgery for supraglottic laryngeal
cancers. Curr Opin Otolaryngol Head Neck Surg. 33:92–101.
2025.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Furusaka T, Matsuda A, Tanaka A, Matsuda H
and Ikeda M: Superselective intra-arterial chemoradiation therapy
for functional laryngeal preservation in advanced squamous cell
carcinoma of the glottic larynx. Acta Otolaryngol. 133:633–640.
2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bonner JA, Harari PM, Giralt J, Azarnia N,
Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al:
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head
and neck. N Engl J Med. 354:567–578. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Machiels JP, Tao Y, Burtness B, Tahara M,
Licitra L, Rischin D, Waldron J, Simon C, Gregoire V, Harrington K,
et al: Pembrolizumab given concomitantly with chemoradiation and as
maintenance therapy for locally advanced head and neck squamous
cell carcinoma: KEYNOTE-412. Future Oncol. 16:1235–1243.
2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Nguyen-Tan PF, Le QT, Quivey JM, Singer M,
Terris DJ, Goffinet DR and Fu KK: Treatment results and prognostic
factors of advanced T3-4 laryngeal carcinoma: The University of
California, San Francisco (UCSF) and Stanford University Hospital
(SUH) experience. Int J Radiat Oncol Biol Phys. 50:1172–1180.
2001.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ramroth H, Schoeps A, Rudolph E, Dyckhoff
G, Plinkert P, Lippert B, Feist K, Delank KW, Scheuermann K, Baier
G, et al: Factors predicting survival after diagnosis of laryngeal
cancer. Oral Oncol. 47:1154–1158. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Daneshi N, Fararouei M, Mohammadianpanah
M, Zare-Bandamiri M, Parvin S and Dianatinasab M: Effects of
different treatment strategies and tumor stage on survival of
patients with advanced laryngeal carcinoma: A 15-year cohort study.
J Cancer Epidemiol. 2018(9678097)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sant M, Allemani C, Santaquilani M, Knijn
A, Marchesi F and Capocaccia R: EUROCARE Working Group. EUROCARE-4.
Survival of cancer patients diagnosed in 1995-1999. Results and
commentary. Eur J Cancer. 45:931–991. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Report of head and neck cancer registry of
Japan 5-year prognosis of patients registered in 2016. http://www.jshnc.umin.ne.jp/pdf/report_yogo_2016_0430.pdf2024.
|
|
44
|
Hoffman HT, Porter K, Karnell LH, Cooper
JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA:
Laryngeal cancer in the United States: Changes in demographics,
patterns of care, and survival. Laryngoscope. 116:1–13.
2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Falco M, Tammaro C, Takeuchi T, Cossu AM,
Scafuro G, Zappavigna S, Itro A, Addeo R, Scrima M, Lombardi A, et
al: Overview on molecular biomarkers for laryngeal cancer: Looking
for new answers to an old problem. Cancers (Basel).
14(1716)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Paget V, Lechevrel M, André V, Goff JL,
Pottier D, Billet S, Garçon G, Shirali P and Sichel F:
Benzo[a]pyrene, aflatoxine B1 and acetaldehyde
mutational patterns in TP53 gene using a functional assay:
Relevance to human cancer aetiology. PLoS One.
7(e30921)2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Urashima M, Hama T, Suda T, Suzuki Y,
Ikegami M, Sakanashi C, Akutsu T, Amagaya S, Horiuchi K, Imai Y, et
al: Distinct effects of alcohol consumption and smoking on genetic
alterations in head and neck carcinoma. PLoS One.
8(e80828)2013.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ronchetti D, Neglia CB, Cesana BM, Carboni
N, Neri A, Pruneri G and Pignataro L: Association between p53 gene
mutations and tobacco and alcohol exposure in laryngeal squamous
cell carcinoma. Arch Otolaryngol Head Neck Surg. 130:303–306.
2004.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chrysovergis A, Papanikolaou V, Tsiambas
E, Stavraka C, Ragos V, Peschos D, Psyrri A, Mastronikolis N and
Kyrodimos E: P53/MDM2 co-expression in laryngeal squamous cell
carcinoma based on digital image analysis. Anticancer Res.
39:4137–4142. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Todorova TA, Jordanov SH, Stancheva GS,
Chalakov IJ, Melnicharov MB, Kunev KV, Mitev VI, Kaneva RP and
Goranova TE: Mutational status of CDKN2A and TP53 genes in
laryngeal squamous cell carcinoma. Pathol Oncol Res. 21:413–421.
2015.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Karakas B, Bachman KE and Park BH:
Mutation of the PIK3CA oncogene in human cancers. Br J Cancer.
94:455–459. 2006.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Nakamura K, Ishikawa M, Kawano R, Aimono
E, Mizuno T, Nohara S, Tanishima S, Hayashi H and Nishihara H: Keio
PleSSision Group. Characterizing multi-PIK3CA mutations across
cancer types: Toward precision oncology. Cancer Med.
13(e70052)2024.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Samuels Y, Wang Z, Bardelli A, Silliman N,
Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al:
High frequency of mutations of the PIK3CA gene in human cancers.
Science. 304(554)2004.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Qiu W, Schönleben F, Li X, Ho DJ, Close
LG, Manolidis S, Bennett BP and Su GH: PIK3CA mutations in head and
neck squamous cell carcinoma. Clin Cancer Res. 12:1441–1446.
2006.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Murugan AK, Hong NT, Fukui Y, Munirajan AK
and Tsuchida N: Oncogenic mutations of the PIK3CA gene in head and
neck squamous cell carcinomas. Int J Oncol. 32:101–111.
2008.PubMed/NCBI
|
|
57
|
Lui VW, Hedberg ML, Li H, Vangara BS,
Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR, et al:
Frequent mutation of the PI3K pathway in head and neck cancer
defines predictive biomarkers. Cancer Discov. 3:761–769.
2013.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Dechaphunkul A, Thongwatchara P,
Thongsuksai P, Dechaphunkul T and Geater SL: Frequency of PIK3CA
mutations in different subsites of head and neck squamous cell
carcinoma in southern Thailand. J Pathol Transl Med. 56:126–133.
2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Borkowska EM, Barańska M, Kowalczyk M and
Pietruszewska W: Detection of PIK3CA gene mutation in head and neck
squamous cell carcinoma using droplet digital PCR and RT-qPCR.
Biomolecules. 11(818)2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Jiang Q, Xiao J, Hsieh YC, Kumar NL, Han
L, Zou Y and Li H: The role of the PI3K/Akt/mTOR axis in head and
neck squamous cell carcinoma. Biomedicines. 12(1610)2024.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Beaty BT, Moon DH, Shen CJ, Amdur RJ,
Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B,
et al: PIK3CA mutation in HPV-associated OPSCC patients receiving
deintensified chemoradiation. J Natl Cancer Inst. 112:855–858.
2020.PubMed/NCBI View Article : Google Scholar
|
